During the past decade, Pacific Diabetes & Endocrine Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Diabetes & Endocrine Center" #1 collaborator was "ARMO BioSciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Diabetes & Endocrine Center" are "Chronic Kidney Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Non Small Cell Lung Cancer" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Pacific Diabetes & Endocrine Center" in a lesser frequency.

Most popular intervention types in "Pacific Diabetes & Endocrine Center" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Kerendia (Finerenone, BAY94-8862)" (1 trials), "Pegilodecakin" (1 trials), "Pembrolizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Diabetes & Endocrine Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Diabetes & Endocrine Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pacific Diabetes & Endocrine Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Diabetes & Endocrine Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".